21st Century advances have brought next-generation sequencing (NGS), a powerful and transformative technology, to the benchtops of laboratories around the world.

NGS enables you to study multiple disease markers from a single sample in a single lab process, making sequencing faster and more cost-efficient than traditional single-gene analysis technologies such as PCR.

Despite many advances in NGS technology and applications, adoption in clinical research has been limited. Reasons include fragmented workflows requiring multiple suppliers, high initial investment costs, and the complexity of analyzing and interpreting vast amounts of genomic data that are beyond human comprehension.

The GeneReader NGS System is for Research Use Only. Not for use in diagnostic procedures.